The medication cycle of Lifnua tablets should be personalized according to the patient's condition and treatment response. It is usually recommended to continue using them under the guidance of a doctor until symptoms are stable and under control. The following provides specific explanations from three aspects: routine treatment, medication for special populations, and precautions.

1. Routine medication cycle

(1) Initial treatment: Most patients require continuous medication for 3-6 months to achieve stable symptom control, while some patients may require even longer periods of time.

(2) Maintenance treatment: After symptom control, gradual reduction may be considered, but regular assessment of the condition is necessary to avoid premature discontinuation of medication and recurrence.

Adjustment for Special Groups 2

(1) Elderly patients: may need to extend the medication cycle and closely monitor drug tolerance.

(2) Liver and kidney dysfunction: The duration of medication should be adjusted based on the results of liver function tests, and those with severe damage should be carefully evaluated.

3 Precautions

(1) Regular follow-up: Efficacy and safety evaluations should be conducted every 3-6 months during the medication period.

(2) Medication discontinuation indication: In the event of serious adverse reactions or ineffective treatment, medication should be promptly discontinued and medical attention sought.